<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20171218037936N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-10-08</date_registration>
      <primary_sponsor>Oroumia University of Medical Sciences</primary_sponsor>
      <public_title>Studying the effect of probiotics on intestinal colonization of pathogenic bacteria and Candida in very low birth weight premature infants admitted to the neonatal intensive care unit</public_title>
      <acronym>PP-VLBW</acronym>
      <scientific_title>Studying the effect of probiotics on intestinal colonization of pathogenic bacteria and Candida in very low birth weight premature infants admitted to the neonatal intensive care unit.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-10-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>130</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/86609</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: Randomization in this study will be carried out using a computer-generated random number sequence created in Microsoft Excel (version …), which will be executed by a research assistant not involved in participant recruitment or clinical care to ensure allocation concealment. Acknowledging the type of feeding as a significant and influential variable, the randomization process will be stratified based on two distinct strata: 'breastfed infants' and 'formula-fed infants'. Within each of these feeding strata, infants will be randomly allocated in a 1:1 ratio to either the intervention group, receiving the probiotic supplement, or the control group, receiving a placebo. This stratified randomization approach ensures a balanced distribution of infants with different feeding patterns across both study groups, thereby enabling a robust and valid comparison of the probiotic's effect.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Intestinal Colonization by multidrug-resistant organisms and Candida species..</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The probiotic group, which includes two subgroups of breastfed infants and formula-fed infants, will be assigned. From the start of feeding, five drops of probiotic Lactobacillus reuteri (Procid) will be given to the infants daily for 5 days.On the sixth day, the newborn's stool will be collected and sent to the laboratory of Shahid Motahari Hospital in Urmia for culture and stool examination. Intervention 2: Control group: Includes two subgroups of breastfed infants and formula-fed infants. On the sixth day, the infants' stool will be collected and sent to the laboratory of Shahid Motahari Hospital in Urmia for culture and stool exam.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Kamran Dehghan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 8, 2nd alley, Adalat Ave., orumieh city</address>
        <city>Orumieh</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5716114819</zip>
        <telephone>+98 44 3365 4154</telephone>
        <email>dehghan.k@umsu.ac.ir</email>
        <affiliation>Oroumia University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Kamran Dehghan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 8, 2nd alley, Adalat Ave., orumieh city</address>
        <city>Orumieh</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5716114819</zip>
        <telephone>+98 44 3365 4154</telephone>
        <email>dehghan.k@umsu.ac.ir</email>
        <affiliation>Oroumia University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Premature, low birth weight (birth weight between 1000 and 1500 grams)
Gestational age less than 32 weeks
Admission to the neonatal intensive care unit (NICU) within the first 72 hours of life</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>3 days</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Dissatisfaction of the patient's parents
Infant with digestive disorders after entering the study (intestinal obstruction, severe digestive diseases, etc.)
Drug allergy
Mortality</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>A04.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Bacterial intestinal infection, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The probiotic group, which includes two subgroups of breastfed infants and formula-fed infants, will be assigned. From the start of feeding, five drops of probiotic Lactobacillus reuteri (Procid) will be given to the infants daily for 5 days.On the sixth day, the newborn's stool will be collected and sent to the laboratory of Shahid Motahari Hospital in Urmia for culture and stool examination.</i_keyword>
      <i_keyword>Control group: Includes two subgroups of breastfed infants and formula-fed infants. On the sixth day, the infants' stool will be collected and sent to the laboratory of Shahid Motahari Hospital in Urmia for culture and stool exam.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Rate of intestinal colonization with pathogenic bacteria based on stool culture. Timepoint: Day 6 after the start of the intervention. Method of measurement: Microbiological culture of stool sample.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Results of the Stool Exam. Timepoint: Day 6 after the start of the intervention. Method of measurement: Direct microscopic examination of the stool sample.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Oroumia University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-09-24</approval_date>
        <contact_name>Ethic committee of Urmia University of Medical Sciences</contact_name>
        <contact_address>Urmia University of Medical Sciences, Orzhans Alley, Resalat St. ,Urmia , Iran Urmia West Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
